Top

Published in:

06-07-2023 | Chronic Kidney Disease | Editorial Commentary

Quality of life in pediatric chronic kidney disease: expectations and responsibilities

Author: Katherine Wesseling-Perry

Published in: Pediatric Nephrology | Issue 12/2023

Excerpt

Prior to the pandemic, depression and anxiety were steadily increasing in children and adolescents. Between 2013 and 2019, 20.9% of adolescents aged 12–17 years reported ever having experienced a major depressive episode. Persistent feelings of sadness or hopelessness increased by 40% between 2009 and 2019 for US high school students, from 26.1 to 36.7% in 2009 and 2019, respectively [1]. In 2019, a shocking 18.8% of teens reported having seriously considered attempting suicide [2]. …

Centers for Disease Control and Prevention (2021) Youth Risk Behavior Survey.

Bitsko RH, Claussen AH, Lichstein J, Black LI, Jones SE, Danielson ML, Hoenig JM, Davis Jack SP, Brody DJ, Gyawali S, Maenner MJ, Warner M, Holland KM, Perou R, Crosby AE, Blumberg SJ, Avenevoli S, Kaminski JW, Ghandour RM (2022) Mental health surveillance among children - United States, 2013–2019. MMWR Suppl 71:1–42CrossRefPubMedPubMedCentral

Carlson J, Gerson AC, Matheson MB, Manne S, Lande M, Harshman L, Johnson RJ, Shinnar S, Kogon AJ, Warady B, Furth S, Hooper S (2023) Longitudinal changes of health-related quality of life in childhood chronic kidney disease. Pediatr Nephrol. https://doi.org/10.1007/s00467-023-06069-8

Norman RE, Byambaa M, De R, Butchart A, Scott J, Vos T (2012) The long-term health consequences of child physical abuse, emotional abuse, and neglect: a systematic review and meta-analysis. PLoS Med 9:e1001349CrossRefPubMedPubMedCentral

Siegel A, Lahav Y (2022) Emotion regulation and distress during the COVID-19 pandemic: the role of childhood abuse. J Interpers Violence 37:NP16302-NP16326

Mazza M, Marano G, Lai C, Janiri L, Sani G (2020) Danger in danger: interpersonal violence during COVID-19 quarantine. Psychiatry Res 289:113046CrossRefPubMedPubMedCentral

Vrantsidis DM, Clark CAC, Chevalier N, Espy KA, Wiebe SA (2020) Socioeconomic status and executive function in early childhood: exploring proximal mechanisms. Dev Sci 23:e12917CrossRefPubMed

Backeljauw P, Cappa M, Kiess W, Law L, Cookson C, Sert C, Whalen J, Dattani MT (2021) Impact of short stature on quality of life: a systematic literature review. Growth Horm IGF Res 57–58:101392CrossRefPubMed

Yu ED, Galbiati S, Munshi R, Smith JM, Menon S, Investigators NAPRTCS (2022) Practice patterns and outcomes of maintenance dialysis in children < 2 years of age: a report of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS). Pediatr Nephrol 37:1117–1124CrossRefPubMed

10.

Cohn LN, Pechlivanoglou P, Lee Y, Mahant S, Orkin J, Marson A, Cohen E (2020) Health outcomes of parents of children with chronic illness: a systematic review and meta-analysis. J Pediatr 218:166-177.e162CrossRefPubMed

11.

Eccleston C, Fisher E, Law E, Bartlett J, Palermo TM (2015) Psychological interventions for parents of children and adolescents with chronic illness. Cochrane Database Syst Rev 4:CD009660

Title: Quality of life in pediatric chronic kidney disease: expectations and responsibilities
Author: Katherine Wesseling-Perry
Publication date: 06-07-2023
Publisher: Springer Berlin Heidelberg
Keyword: Chronic Kidney Disease
Published in: Pediatric Nephrology / Issue 12/2023
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI: https://doi.org/10.1007/s00467-023-06070-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Quality of life in pediatric chronic kidney disease: expectations and responsibilities

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 12/2023

Live attenuated vaccines in patients receiving immunosuppressive agents

Plasma leucine-rich α-2-glycoprotein 1 – a novel marker of diabetic kidney disease in children and adolescents with type 1 diabetes mellitus?

Associations between collagen X biomarker and linear growth velocity in a pediatric chronic kidney disease cohort

The first randomized controlled trial in pediatric nephrology: the history of the International Study of Kidney Disease in Children (ISKDC)

Eculizumab use in patients with pneumococcal-associated hemolytic uremic syndrome and kidney outcomes

Evidence of increased vascular stiffness and left ventricular hypertrophy in children with cystic kidney disease